Pimstone Simon N.
Former Director at XENE
- Sold, on record
- $15M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jun 1, 2023
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- XENEXenon Pharmaceuticals Inc.Former Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale XENEUnusualAug 16, 2022 2022
Sold 177,135 shares at $38.25 ($6.8M)
Pimstone Simon N., Director
Sold 96.7% of holdings ($7M position)6,000 shares leftFiling
- 2 Form 4 sale XENEUnusualMar 7, 2023 +203 days
Sold 19,232 shares at $36.98 ($711k)
Pimstone Simon N., Director
Sold 25.9% of holdings ($2.7M position)55,006 shares left0.3x usual sizeFiling
- 3 Form 144 notice XENENoticeMay 30, 2023 +84 days
Filed to sell 37,006 shares ($1.4M)
Pimstone Simon N., Director
No 10b5-1 plan1x usual sizeFiling
- 4 Form 144 notice XENENoticeMay 31, 2023 +1 day
Filed to sell 62,526 shares ($2.4M)
Pimstone Simon N., Director
No 10b5-1 plan1.7x usual sizeFiling
- 5 Form 4 sale XENEUnusualJun 1, 2023 +1 day
Sold 131,245 shares at $38.90 ($5.1M)
Pimstone Simon N., Director
No 10b5-1 planSold 95.6% of holdings ($5.3M position)6,000 shares left3.5x usual sizeFollows a Form 144Filing
- 6 Form 144 notice XENENoticeJun 1, 2023 same day
Filed to sell 31,713 shares ($1.2M)
Pimstone Simon N., Director
No 10b5-1 plan0.9x usual sizeFiling
- 7 Form 144 notice XENENoticeJun 5, 2024 +370 days
Filed to sell 110,000 shares ($4.2M)
Pimstone Simon N., Former Director
No 10b5-1 plan0.8x usual sizeFiling
- 8 Form 144 notice XENENoticeJul 12, 2024 +37 days
Filed to sell 70,000 shares ($3M)
Pimstone Simon N., Former Director
No 10b5-1 plan0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 12, 2024 | Jul 12, 2024 | XENE | Former Director | Form 144 notice | 70,000 | $3M | Notice | SEC | |
| Jun 5, 2024 | Jun 5, 2024 | XENE | Former Director | Form 144 notice | 110,000 | $4.2M | Notice | SEC | |
| Jun 1, 2023 | Jun 1, 2023 | XENE | Director | Form 144 notice | 31,713 | $1.2M | Notice | SEC | |
| Jun 1, 2023 | Jun 1, 2023 | XENE | Director | Form 4 sale | 131,245 | $5.1M | 95.6% | Unusual | SEC |
| May 31, 2023 | May 31, 2023 | XENE | Director | Form 144 notice | 62,526 | $2.4M | Notice | SEC | |
| May 30, 2023 | May 30, 2023 | XENE | Director | Form 144 notice | 37,006 | $1.4M | Notice | SEC | |
| Mar 7, 2023 | Mar 9, 2023 | XENE | Director | Form 4 sale | 19,232 | $711k | 25.9% | Unusual | SEC |
| Aug 16, 2022 | Aug 16, 2022 | XENE | Director | Form 4 sale | 177,135 | $6.8M | 96.7% | Unusual | SEC |
| Mar 8, 2022 | Mar 8, 2022 | XENE | Director | Form 4 sale | 54,962 | $1.6M | 23.1% | Plan not stated | SEC |
| Nov 15, 2021 | Nov 16, 2021 | XENE | Director | Form 4 sale | 17,557 | $550k | 7.7% | Plan not stated | SEC |
| Jun 1, 2020 | Jun 2, 2020 | XENE | CEO | Form 4 sale | 8,000 | $113k | 3.0% | Plan not stated | SEC |
| Sep 20, 2019 | Sep 24, 2019 | XENE | CEO | Form 4 sale | 10,395 | $99k | 3.9% | Plan not stated | SEC |